Oncology Nursing News® will be hosting its first tweet chat on May 23, at 1 p.m. ET, to discuss findings presented at the Oncology Nursing Society's Annual Conference, held May 17-20 in Washington, DC.
Oncology Nursing News® will be hosting its first tweet chat on May 23, at 1 p.m. ET, to discuss findings presented at the Oncology Nursing Society's (ONS) Annual Conference, held May 17-20 in Washington, DC.
“We are excited to launch the inaugural tweet chat on the oncology nursing society’s annual conference. This tweet chat will inform the audience on the highlights and news that came out of the conference,” said Michael J. Hennessy Jr., president of MJH Associates, parent company of Oncology Nursing News®.
Oncology Nursing News® welcomes all professionals within the oncology nursing specialty group to join the discussion using the hashtag #OncNurseConnect. Highlights to be discussed:
Read more ONS Congress conference coverage
Dual Checkpoint Inhibition Increases Response Rates, Adverse Effects in Melanoma
April 19th 2024Patients with high-risk resectable melanoma treated with ipilimumab plus nivolumab had increased response rates compared with anti-PD1 monotherapy, though it was also associated with increased immune-related adverse effects.